PEPPOLONI, Samuele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.547
NA - Nord America 13.861
AS - Asia 7.670
SA - Sud America 893
AF - Africa 157
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 11
Totale 44.158
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.662
US - Stati Uniti d'America 13.587
SG - Singapore 2.732
GB - Regno Unito 2.198
CN - Cina 1.990
HK - Hong Kong 921
DE - Germania 743
FR - Francia 692
VN - Vietnam 669
BR - Brasile 657
SE - Svezia 653
UA - Ucraina 346
FI - Finlandia 272
RU - Federazione Russa 271
BD - Bangladesh 247
TR - Turchia 243
KR - Corea 209
IN - India 173
MX - Messico 129
BG - Bulgaria 122
NL - Olanda 97
CA - Canada 92
AR - Argentina 90
AT - Austria 80
ID - Indonesia 80
IQ - Iraq 67
PL - Polonia 61
JP - Giappone 51
BE - Belgio 50
RO - Romania 49
ZA - Sudafrica 47
ES - Italia 40
IE - Irlanda 40
PK - Pakistan 36
AE - Emirati Arabi Uniti 33
CH - Svizzera 33
MA - Marocco 32
CL - Cile 26
CO - Colombia 26
EC - Ecuador 24
VE - Venezuela 24
UZ - Uzbekistan 23
PH - Filippine 22
MY - Malesia 21
PT - Portogallo 20
LT - Lituania 19
AU - Australia 17
CZ - Repubblica Ceca 17
IR - Iran 17
KE - Kenya 17
PY - Paraguay 17
TH - Thailandia 16
JO - Giordania 15
EG - Egitto 12
IL - Israele 12
CR - Costa Rica 11
DK - Danimarca 11
NP - Nepal 11
PE - Perù 11
SA - Arabia Saudita 11
TN - Tunisia 11
DZ - Algeria 10
TW - Taiwan 10
KG - Kirghizistan 9
UY - Uruguay 9
AL - Albania 8
HN - Honduras 8
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
EU - Europa 7
NO - Norvegia 7
PA - Panama 7
EE - Estonia 6
GR - Grecia 6
KH - Cambogia 6
QA - Qatar 6
RS - Serbia 6
BO - Bolivia 5
BY - Bielorussia 5
GE - Georgia 5
MT - Malta 5
SN - Senegal 5
AM - Armenia 4
ET - Etiopia 4
HR - Croazia 4
JM - Giamaica 4
SM - San Marino 4
BH - Bahrain 3
KW - Kuwait 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
LV - Lettonia 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AN - Antille olandesi 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
CG - Congo 2
Totale 44.102
Salva come PNG Salva come JPEG
Città #
Singapore 1.991
Southend 1.564
Santa Clara 1.441
Ashburn 1.211
Hong Kong 911
Fairfield 855
Chandler 781
Milan 679
Woodbridge 645
Hefei 631
San Jose 603
Jacksonville 601
Rome 597
Houston 511
Bologna 453
Dearborn 446
Ann Arbor 444
Beijing 391
Wilmington 349
Nyköping 335
Seattle 317
Torino 290
Chicago 288
Los Angeles 287
Council Bluffs 282
London 281
Florence 235
Modena 230
Cambridge 229
New York 202
Ho Chi Minh City 193
Seoul 193
The Dalles 162
Helsinki 157
Hanoi 152
Catania 149
Genova 125
Dallas 123
Verona 119
Padova 118
Princeton 118
Sofia 117
Izmir 115
Salt Lake City 110
Castelnuovo Rangone 105
Bremen 103
Eugene 102
Moscow 101
Venezia 101
Lauterbourg 96
Napoli 94
Des Moines 93
Turin 93
San Diego 92
Munich 89
Shanghai 82
Pisa 81
Mexico City 80
Nuremberg 77
Palermo 77
Reggio Nell'emilia 77
Redwood City 76
Buffalo 75
Bari 71
São Paulo 71
Naples 69
Trento 66
Orem 62
Elk Grove Village 58
Tampa 58
Trieste 56
Boardman 51
Parma 51
Bolzano 50
Piemonte 50
Jakarta 49
Falls Church 47
Genoa 47
Da Nang 46
Udine 46
Monza 45
Oggiono 45
Tokyo 45
Vienna 43
Chennai 42
Norwalk 42
Frankfurt am Main 41
Messina 40
Dublin 37
Nanjing 35
Pavia 35
Brussels 34
Columbus 34
Atlanta 33
Reggio Emilia 33
Rio Saliceto 33
Cagliari 32
Mountain View 32
Phoenix 32
Stockholm 31
Totale 23.417
Salva come PNG Salva come JPEG
Nome #
RICERCA DI MARCATORI PER LA DIAGNOSI DI INFEZIONE FUNGINA INVASIVAE (IFI) MEDIANTE APPROCCIO DIAGNOSTICO COMBINATO 15.265
Ruolo della proteina pneumococcica di superficie PspC nel l’interazione in vitro di Streptococcus pneumoniae con le cellule microgliali 461
Yessotoxin inhibits phagocytic activity of macrophages. 454
The encapsulated strain TIGR4 of Streptococcus pneumoniae is phagocytosed but is resistant to intracellular killing by mouse microglia 441
Adaptive response of microglial cells to in vitro infection by Candida albicans isolates with different genomic backgrounds 434
Longitudinal Survey of Fungi in the Human Gut: ITS Profiling, Phenotyping, and Colonization 416
A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections 412
EFFETTI DELLA TOSSINA DI ORIGINE ALGALE YESSOTOSSINA (YTX) SULLA ATTIVITA’ DEL MACROFAGO 409
RUOLO BIOLOGICO DI DUE RECETTORI TOLL-SIMILI, TLR2 E TLR4, NELLA RISPOSTA MACROFAGICA A CANDIDA ALBICANS 399
Genomic and phenotypic variation in morphogenetic networks of two Candida albicans isolates subtends their different pathogenic potential 391
La proteina di superficie PspC di pneumococco conferisce resistenza al killing in vitro di Streptococcus pneumoniae da parte di cellule microgliali in maniera indipendente dal complemento 389
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 387
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 383
A synthetic killer peptide impairs Candida albicans biofilm formation and persistence in vitro 366
Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome λ-display library 365
Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro 352
Detection of follicular fluid and serum antibodies by protein microarrays in women undergoing in vitro fertilization treatment. 350
NF-kB activation and p38 phosphorilation in microglial cells infected with Leptospira or exposed to partially purified leptospiral lipoproteins 345
Effects of Cupral® on the formation and persistence of microbial biofilms in vitro 340
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 339
An antibody reactivity-based assay for diagnosis of invasive candidiasis using protein array 338
Compounds released from Lactobacillus (L.) acidophilus, L. plantarum, L. rhamnosus and L. reuteri inhibit Candida parapsilosis pathogenic potential after infection of vaginal epithelial cells in vitro. 338
Role of the (Mn)superoxide dismutase of Enterococcus faecalis in the in vitro interaction with microglia 332
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 330
ALTERATA REATTIVITA’ MACROFAGICA IN CORSO DI INFEZIONE MISTA DA VIRUS E FUNGHI:VALUTAZIONI FUNZIONALI, CITOFLUORIMETRICHE E DI ESPRESSIONE GENICA 326
Acellular pertussis vaccines composed of genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults. 324
Safety and immunogencity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study 319
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 310
Contribution of different pneumococcal virulence factors to experimental meningitis in mice 309
Antimicrobial and antibiofilm efficacy of a copper/calcium hydroxide-based endodontic paste against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans 307
MESSA A PUNTO DI UN SISTEMA INNOVATIVO PER MONITORARE IN TEMPO REALE LA FORMAZIONE DI BIOFILM DI PSEUDOMONAS AERUGINOSA SU TUBI ENDOTRACHEALI 303
Gene expression profiling of monocytes displaying herpes simplex virus 1 induced dysregulation of antifungal defences 296
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old children. 293
The lack of Pneumococcal surface protein C (PspC) increases the susceptibility of Streptococcus pneumoniae to the killing by microglial cells 290
CANDIDA ALBICANS HYPHAL DEVELOPMENT AND BIOFILM FORMATION/PERSISTENCE ARE DIFFERENTIALLY AFFECTED BY MOUTHWASHES DEPENDING UPON THEIR COMPOSITION. 289
Diagnostic utility of a microarray based on 11 proteins of Candida albicans for the diagnosis of invasive candidiasis 285
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 284
Antibody-dependent macrophage-mediated activity against Helicobacter pylori in the absence of complement 280
Candida albicans survival, growth and biofilm formation are differently affected by mouthwashes: an in vitro study 274
RUOLO DELLA SUPEROSSIDO DISMUTASI DI Enterococcus faecalis SULLA REATTIVITA’ DELLA MICROGLIA IN VITRO 272
The quest for a vaccine against Helicobacter pylori: how to move from mouse to man? 271
Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans 268
New strategies for the prevention and treatment of Helicobacter pylori infection 265
Caratterizzazione immunobiologica di nuovi antigeni proteici di Streptococcus pneumoniae selezionati mediante "phage display" 265
The Spr1875 protein confers resistance to the microglia-mediated killing of Streptococcus pneumoniae 265
Immunogenicity of the B monomer of Escherichia coli heat-Labile Toxin expressed on the surface of the Streptococcus gordonii 264
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 response following nasal delivery 257
Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: Safety, immunogenicity, and efficacy 256
The TIGR4 strain of Streptococcus pneumoniae is phagocytosed but resists intracellular killing by microglia in experimental pneumococcal meningitis 256
Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. 254
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin 253
The Pneumococcal surface protein C (PspC) influences the susceptibility of Streptococcus pneumoniae to microglia 250
Mutants of Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines. 247
COMPARAZIONE DELLA EFFICACIA ANTIBATTERICA DI TETRACLEAN, UN IRRIGANTE ENDODONTICO DI NUOVA GENERAZIONE, CON IPOCLORITO DI SODIO. 246
Attenuation of Pseudomonas aeruginosa Virulence by Pomegranate Peel Extract 245
Immunostimulation by a partially retro-inverso tuftsin analogue containing Thr 1 (NHCO) (R,S) Lys 2 modification 244
Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity 244
Applicazioni del microarray proteico nella diagnosi diretta per la sierotipizzazione di agenti patogeni 243
Metabolic, humoral and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G 242
The Spr1875 protein of Streptococcus pneumoniae protects the bacterium from microglia-mediated killing 242
Immunogenic Properties of Streptococcus agalactiae FbsA Fragments 240
Host-microbe interaction in Candida mucosal infections: a complex balance (Interazione ospite-microrganismo nelle infezioni mucosali da Candida: un equilibrio complesso) 240
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 238
APPLICAZIONE DEI MICROARRAY PROTEICI NELLA DIAGNOSTICA AVANZATA DI PATOLOGIEMICROBICHE E VIRALI 235
The ABC transporter-encoding gene AFR1 affects the resistance of Cryptococcus neoformans to microglia-mediated antifungal activity by delaying phagosomal maturation. 234
Safety and immunogenicity in animals of subunit influenza vaccine given intranasally with mutants of Escherichia coli heat-labile enterotoxin (LT) 233
Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine 228
Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform 227
The protein “mycoarray”: a novel serological assay for the laboratory diagnosis of primitive endemic mycoses 225
In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets. 225
Alterazione delle difese monocito-mediate nei confronti di miceti in presenza di virus erpetici 223
Lymphokine secretion and cytotoxic activity of human CD4+ T cell clones against Bordetella pertussis 222
Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis 222
Alterazione delle difese monocito-mediate nei confronti di Cryptococcus neoformans in presenza dell’Herpesvirus umano 6 221
IL MICROARRAY PROTEICO NELL’ANALISI DEI LIQUIDI AMNIOTICI: RICERCA DI MARKER PRECOCI DI INFIAMMAZIONE E/O INFEZIONE CORRELABILI AL PARTO PRETERMINE 217
Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizaztion 213
MICROARRAY PROTEICI NELLA DIAGNOSI DIRETTA: SIEROTIPIZZAZIONE DI AGENTI PATOGENI 213
Physicochemical characterisation of the pertussis vaccine. 212
Immunobiological characterization of genetic products, identified from whole genome lambda-display libraries of Pneumococcus 211
Probing the structure-activity relationship of E.coli LT-A by site directed mutagenesis 211
Interaction of pneumococcal surface structures with microglia 208
Pneumocystis jirovecii genotyping: experience in a tertiary-care hospital in Northern Italy 202
Bordetella 200
Protein microarrays on midtrimester amniotic fluids: a novel approach for the diagnosis of early intrauterine inflammation related to preterm delivery 200
A short synthetic peptide fragment of human interleukin-1 beta increases both human and murine natural killer activity 198
EDTA and Taurolidine affect Pseudomonas aeruginosa virulence in vitro: impairment of secretory profile and biofilm production onto peritoneal dialysis catheters 196
Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm development. 194
RUOLO DI PRODOTTI GENICI IDENTIFICATI MEDIANTE LIBRERIE LAMBDA-DISPLAY DA GENOMA COMPLETO DI PNEUMOCOCCO NELL’INTERAZIONE IN VITRO CON CELLULE MICROGLIALI ED EPITELIALI 193
LA PROTEINA SPR1875 DI STREPTOCOCCUS PNEUMONIAE PROTEGGE IL BATTERIO DAL KILLING DELLA MICROGLIA 192
Pomegranate extract affects fungal biofilm production: consumption of phenolic compounds and alteration of fungal autoinducers release 188
Il gene AFR1 di Cryptococcus neoformans codificante per un trasportatore ABC, altera la resistenza del patogeno alla microglia: ritardo nella maturazione dei fagosomi. 187
Properties of the pertussis toxin mutant PT-9K/129G after formaldehyde treatment. 185
Brucella 184
Risposta differenziale della cellula di microglia ad isolati clinici di Candida albicans con differente genotipo 183
Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells 183
Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 K 181
Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with FHA and pertactin in infants and children 171
Vaginal Clinical Isolates of Candida albicans Differentially Modulate Complosome Activation in Vaginal Epithelial Cells 166
Ruolo del sierotipo capsulare nella suscettibilità di Streptococcus pneumoniae alla cellula microgliale 166
Protective activity of a protein fragment identified by screening of a phage display genomic library of Streptococcus pneumoniae 165
Totale 42.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.803
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.803
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021244 0 0 0 0 0 0 0 0 0 0 0 244
2021/20222.991 187 281 219 250 168 192 194 209 273 206 437 375
2022/20234.240 398 344 313 375 465 519 210 412 470 152 257 325
2023/20242.432 220 236 218 204 364 203 222 207 96 112 130 220
2024/20255.361 228 167 110 360 1.049 735 404 362 561 203 527 655
2025/202610.415 620 472 686 1.584 2.161 656 1.045 442 934 908 526 381
Totale 44.534